Policy / European Union
PRIME Scheme: Fast-Tracking Revolutionary Medicines in the EU
The European Medicines Agency's PRIME initiative aims to expedite the development and assessment of innovative treatments, focusing on medications addressing high unmet medical needs.
Explained
Affected: Businesses, Workers
European Union
08 May 2026